corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 17377

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Report

Society of General Internal Medicine
Policy on Acceptance and Disclosure of External Funds
Society of General Internal Medicine 2002 Aug 2


Full text:

INTRODUCTION

The primary goal of the Society of General Internal Medicine is to support its members in their efforts to promote improved patient care, teaching, and research in primary care and general internal medicine. The SGIM Council may promote these goals by accepting external funds such as grants, sponsorships, or gifts in support of activities designed to meet this goal. This policy provides guidelines for the negotiation and acceptance of such funds. It provides guidance for all external funding relationships and is not limited to commercial relationships. External funds targeted for support of national and regional SGIM meetings are also covered by this policy. Individuals and groups who solicit funds on behalf of SGIM should be familiar with these guidelines. This policy has evolved from the original SGIM Policy regarding Acceptance of External Funds, which was approved on January 6, 1994 and amended on December 3, 2000. It also subsumes two previous appendices to that document adopted February 10, 2000 and March 3, 2000.

BACKGROUND

External funds may help SGIM pursue its mission in several ways. Examples include:

-Helping SGIM undertake initiatives to promote patient care, teaching, and research in general internal medicine;

-Improving the quality of SGIM meetings by allowing the Society to reimburse speakers, provide honoraria, furnish amenities, give scholarships and awards, or offer general programming that might otherwise be unavailable; and

-Helping SGIM provide services of value to members that advance the goals of the society, such as the SGIM website, email, and listserver systems.

In short, external funds potentially allow SGIM to pursue worthwhile activities that it might otherwise have to forgo.

Notably, any financial relationship with an external funder may create a potential conflict of interest for SGIM. Conflicts of interest are common and not by themselves unethical. Regardless of whether the conflict of interest results in inappropriate action, the appearance of a conflict of interest may be damaging to SGIM’s reputation. Concerns that the acceptance of external funds creates an inappropriate conflict of interest, with the greatest potential for inappropriate action, are particularly acute in two situations: when external funding is from for-profit companies (or not-for-profit entities funded largely by for-profit companies); and when the amount of external funding, particularly from a single source, becomes large enough to create dependence.

With these observations of the benefits and risks of external funding in mind, SGIM has established the following guidelines for the acceptance of external funds.

GUIDELINES FOR THE ACCEPTANCE OF EXTERNAL FUNDS

Projects in General. SGIM should accept external funds only for high quality projects that are:

-consistent with the SGIM mission , “To promote improved patient care, teaching and research in primary care and general internal medicine”; -judged to be particularly well suited to be carried out by SGIM as an organization (especially in contradistinction to individual Society members or groups of members working through their own institutions), especially if SGIM is to be the primary recipient of external funds for the proposed project; and -judged to be unlikely to create undue competition with individual SGIM members’ pursuits of funding for their own research or educational projects.

The authors of this policy acknowledge that there will be subjectivity in decisions regarding which projects are particularly well suited to be carried out by SGIM (particularly as primary recipient of external funding), and which projects are unlikely to cause undue competition with its members for funding. In general, projects for which SGIM is particularly well suited create the opportunity for participation of large numbers of SGIM members in ways that would be difficult or impossible to arrange through standard mechanisms of funding to hospitals and universities. Undue competition is more likely to be a problem when SGIM responds to requests for proposals and applications from funders which are also likely to attract proposals and applications from individual members or groups of members. When more than one SGIM member independently approaches the organization regarding obtaining funding for a project of a similar nature, and particularly when SGIM’s participation would be mutually exclusive, every effort should be made to foster collaboration among the interested individuals so that a single project proposal results. If, despite these efforts, more than one proposal is submitted for a similar project, and SGIM’s participation is mutually exclusive, these projects would be reviewed in parallel, with heightened concern about undue competition.

In addition, SGIM should not accept external funds, either directly or indirectly as a subcontractor to another entity, from for-profit companies (or not-for-profit entities funded largely by for-profit companies) for research or educational projects (including precourses, workshops or other presentations at the national or regional meetings) related to specific pharmaceuticals, medical devices, diagnostics, or any other product purported to have direct health benefits to patients (regardless of whether the products are sold by that particular external funder). In addition, SGIM shall not accept external funds from companies that make or sell tobacco products, including other companies owned by tobacco companies, or their parent companies.

Finally, dependence is potentially created when SGIM’s core operations become too reliant on external funding. External funds that “pass through” SGIM to other individuals and groups for the accomplishment of specific projects or for awards do not create dependence, nor do funds that are saved by SGIM for future disbursement for these purposes. An exception would be external funds for payment of travel expenses for SGIM members to speak at regional or national meetings, or trainee travel awards, which do have the potential of creating dependence. The SGIM operating budget best reflects expenses for core activities; it is the proportion of external funds that comprise the operating budget that, if too high, raise concerns about dependence. In this context, “internal” funds are considered revenues from dues, meeting and course registrations, serial publications (including subscriptions and royalities from the Journal of General Internal Medicine), sales of products and services to members, and member donations. “External” funds are revenues from all other sources. External funds used specifically for the Society’s operations and included in the annual operating budget should not comprise more than approximately 25% of the Society’s annual operating budget, and no more than approximately 5% of the Society’s operating budget should be derived from any single for-profit source of external funding (see Appendix 1 for details on this calculation). These limits will also apply to the operating budgets of each SGIM region (which generally will be dominated by the costs of the respective regional meetings), with the exception that the limit on funding from any single for-profit source will be $2000.00 or 5% of the operating budget, whichever is higher.

Educational Projects. SGIM must retain ultimate control over educational content, selection of speakers, review of educational materials, selection of research for presentation, or other public activities with scientific content that are financed with external funds. Precourses, workshops, or other educational presentations at the national and regional meeting are considered educational projects from the perspective of this policy. When external funding is solicited for national or regional meetings, the meeting program should be determined before funding is solicited, to ensure the independence of meeting program planning from the interests of external funders.

Research Projects. SGIM will retain control of the selection of project personnel and other activities for the conduct of research activities for which the Society accepts external funding.

Use of Human Subjects. If an externally funded research or educational project involving SGIM requires use of human subjects in any way, it is the responsibility of the project’s proponents to obtain appropriate IRB approval(s) from their own institution(s). SGIM will not maintain a central IRB.

Freedom to Publish Results. The proponents of any externally funded research or educational project involving SGIM shall have the right to publish their findings without interference from the external funder. Only nonbinding, expeditious review and comment on written results by the external funder is acceptable. The Society encourages but neither requires nor commits to publication of the results of these projects in the Journal of General Internal Medicine.

Intellectual Property. When SGIM serves as the primary entity accepting external funds for a research or educational project, SGIM reserves the right to all intellectual properties resulting from the project. When SGIM collaborates with another entity that is the primary recipient of funds for the project, that entity, usually the project proponent’s academic institution, will generally have the right to all intellectual properties resulting from the project. In the latter case, an agreement regarding intellectual property must be documented in writing between the concerned institutions and SGIM and approved by Council.

Budgets. When externally funded research or educational projects require using SGIM resources at the national office, a budget for those activities should be negotiated between the Executive Director and the SGIM members responsible for the project to cover the direct costs of SGIM’s participation. In general, to cover SGIM’s indirect costs, an additional percentage reflecting the Society’s overhead costs as negotiated with the Federal government (currently 30%) will be added to the budgeted direct costs (but not to other funds that “pass through” SGIM to other parties for completion of the project). The final budget for each project, including any deviations from the usual overhead rate, must be approved by the SGIM Treasurer. External funds for awards, which reflect acknowledgment for completed work or funding for new work or activities to be done independently of SGIM, and which require minimal use of resources at the SGIM central office, as judged by the Executive Director, do not require a specific budget. Rather, a reduced overhead rate of 10% will be added to the total amount of the award to account for the Society’s costs for publicizing, selecting, and administrating the award. External Funds solicited for such awards will be kept in restricted accounts that cannot be used for other purposes (especially operations). Only when funds are disbursed for an award will the Society’s overhead be applied to the disbursed amount, and the amount of the overhead be included in the numerator of the calculation of the proportion of the operating budget derived from external funding in that year.

Projects with an Internal Selection Process. When SGIM accepts external funds for research or educational projects that involve a competitive selection process with submitted proposals, the external funder can have limited input in the selection criteria for which proposals will receive funding, and will receive information about which proposals did and did not receive funding. However, final funding decisions will be made by a group designated by SGIM, independent from the external funder. This group may include both SGIM and non-SGIM members.

Awards. When SGIM accepts external funds for awards, which reflect acknowledgment for work already completed, awardees will be selected based on criteria established by SGIM. The sponsor may have limited input in the selection criteria but SGIM retains ultimate control over selection of the award recipient. The sponsor can impose no obligations on the recipient of an award.

Access to SGIM Members. Access to SGIM members or to recipients of external funds shall not be a condition of support from an external funder, including access through talks by representatives of the external funder at regional or national meetings.

Disclosure. SGIM should disclose all sponsored activities that are partially or completely financed by external funds, including but not limited to research grants, presentations and publications, and support of policy efforts (see subsequent section of procedures for disclosure).

Business Relationships. SGIM may establish a business relationship with an individual, group, or organization to endorse, develop, distribute, or sell products or services; for example, journals, books, software, or other educational products. However, acceptance of any funds that come to SGIM from these relationships will be governed by these guidelines for external funding of projects. For example, SGIM shall not receive funding to endorse, develop, distribute, or sell products such as pharmaceuticals, medical devices, diagnostics, or other products purported to have a direct health benefit to patients. In addition, SGIM shall not enter business relationships with companies that make or sell tobacco products, including other companies owned by tobacco companies, or their parent companies.

Acknowledgments. Tasteful acknowledgment of external funders may be made in the Society’s publications, meeting materials, or reports of project results, as appropriate. These acknowledgments should not advertise any products or services of the funder. Ultimate decisions about the tastefulness and appropriateness of any acknowledgments of external funding rests with the Society.

Advertising. The Journal of General Internal Medicine may accept advertisements for medically-related products and services. Final judgment regarding the appropriateness and acceptability of advertisements rests with the Journal’s editorial staff. Advertising (except for classified advertising of positions available and announcements) will not be accepted for the Society’s other publications, including the SGIM Forum and web site.

Because the opportunities for external funding for valuable projects are varied and to some extent unpredictable, exceptions to these guidelines may be appropriate in some circumstances. Any exceptions, however, must be approved by the SGIM Council. As circumstances may also change over time, this policy should be reviewed at least every three years by Council and amended if necessary.

PROCEDURES FOR REVIEWING EXTERNAL FUNDING

-All SGIM members, staff, or consultants involved in negotiations with external funders should be familiar with this policy. The initiation of the approval process should begin early in any quest for external funding, ideally when an SGIM member or group of members first conceives of a project requiring SGIM’s participation and external funding, or when an SGIM member or group of members is first approached by an external funder about a potential project requiring SGIM’s participation.

-General contributions, including contributions for the national meeting and for awards, will be handled directly by the Development Committee. All general contributions, except unrestricted educational grants less than $5,000, will also be reviewed by the chair of the Ethics Committee. Most general contributions over $5,000 will not raise concerns from the perspective of this policy. However, any general contribution that raises concerns will undergo a full Ethics Committee review (see below). For unrestricted educational grants less than $2,000 for regional meetings, the regional officers can accept contributions that fall within this policy, in place of the Development Committee. Regional officers should feel free to consult the Development and/or Ethics Committee Chairs if they have questions about particular contributions, and must do so for contributions larger than $2,000.

-Proposals for research or educational projects requiring external funding and for which the applicant(s) request SGIM’s involvement should come from an SGIM member or groups of members (with one member designated as the main point of contact).

-At minimum, proposals for research or educational projects should include a standard cover page and a three page (maximum) abstract describing the project’s objectives, methodology, timetable, the estimated budget and proposed source of external funding, human subjects/IRB issues, and how it satisfies the SGIM guidelines for the acceptance of external funds. A biographical sketch of each key participant should be included. Additional supporting materials may be included. A template for proposals for externally funded research or educational projects is included as Appendix 2 of this policy.

-Proposals for research or educational projects should be submitted to the SGIM Development Director, who will triage them as follows:

-Research projects will go to the Chair of the Research Committee

-Educational projects will go to the Chair of the Education Committee

The Chairs of these committees will preliminarily review the proposal (in consultation with the Executive Director), focusing on compliance with the external funding guidelines and feasibility of the project, and either reject the proposal, return the proposal to the applicant(s) for revision, or forward the proposal along for a full review. Full review would be undertaken by a subcommittee of each committee consisting of three members, with approval to move the project forward required from at least two of the three members. Reviewers would be asked to declare any potential conflicts of interest in their evaluation of assigned proposals; occasionally, such a declaration may lead the Committee Chair to replace a reviewer.

-In parallel, each proposal for external funding for research or educational projects forwarded for a full review by the Research or Education Committee will also be reviewed in parallel by the Chair of the Ethics Committee. If any concerns are raised, the Chair of the Ethics Committee will appoint three Ethics Committee members to perform a full Ethics review. Once again, approval to move the project forward would be required by at least two out of the three members.

-During the period of full review, the proposal would be posted on the SGIM web site, and all SGIM members with active email addresses in the Society’s membership database would receive a brief message about the nature of the project under review, referring them to the full proposal. Any concerns of individual members, especially regarding competition with their own efforts, should be communicated to the Chair of the Research or Education Committee within two weeks of the posting. These messages would in turn be forwarded to the Committee members performing the full review, and considered in the deliberations regarding project approval.

-Projects approved to move forward by both the Education or Research Committee and the Ethics Committee would then be reviewed by the SGIM Treasurer, particularly regarding whether the new funding would bring the total amount of external funding above acceptable thresholds for the year, and forwarded to the SGIM Council for final approval at a monthly conference call or meeting. The goal of the entire review process should be to accept or reject proposals within 60 days of submission.

-SGIM acknowledges that occasionally opportunities for externally funded research or educational projects may be time-limited. If a decision on SGIM’s participation must be made in less than 60 days, a letter requesting an expedited review can accompany the proposal. Decisions regarding the desirability, practicality, and mechanisms of an expedited review will be made by the Executive Director, in consultation with the Chairs of the appropriate Committees (Research or Education and Ethics).

-If a proposal is not recommended for further consideration at any stage of the process, the proponents may appeal the decision in writing to the SGIM Executive Committee. The Executive Committee may confirm or overide the original decision; in the latter case, the proposal would proceed to (but not circumvent) the next step in the review process.

PROCEDURES FOR DISCLOSURE OF EXTERNAL FUNDING

-When external funding supports presentations or awards at regional or annual meetings, the program for the meeting should indicate the sources and nature of external support. Speakers should disclose whether any part of their presentation resulted from external funding and whether they have any personal financial interest in the subject matter of the presentation.

-All externally funded research and educational projects will be posted on the SGIM web site by leaving the project descriptions, originally posted for member review and comment, on the site with an indication that funding was ultimately accepted for the project.

-The SGIM Treasurer will prepare an annual report on the sources and amounts of external funding (both at the national level and for each region) at the end of each fiscal year, along with a calculation of the proportion of the operating budget for the fiscal year derived from external funding. The report, when accepted by Council, will also be posted on the SGIM web site.

Appendix 1. Calculating the proportion of the SGIM Approved Budget (for the current fiscal year) supported by external funding (non-member revenue).

THE EQUATION:

X source of funding
that affects approved budget
_________________ = % of approved budget (for current fiscal year) supported by that source
approved budget

EXAMPLES:

1. SGIM receives a $25,000 contribution from Aventis to support the Research & Education Mentorship Program. SGIM takes 10% overhead on award contributions. In the equation… $2,500 is the numerator. $1,959,444 is the denominator. Divide, and the result is the percentage of the approved budget that is supported by this particular contribution. (= .1% ) 2. SGIM receives a $50,000 from AHRQ to support an EBM workshop. SGIM has a federally negotiated overhead rate of 30%. In the equation… $15,000 is the numerator. $1,959,444 is the denominator. Divide, and the result is the percentage of the approved budget that is supported by this particular contribution. (= .8% )

Source of External Funding per Fiscal Year

Cannot Support More Than:
Combined External Funding (all non-member revenue)

25% of SGIM’s operating budget
Combined Pharmaceutical Funding

10% of SGIM’s operating budget
Single Pharmaceutical Contribution

5% of SGIM’s operating budget
Single For-Profit (excluding Pharmaceuticals) Contribution

10% of SGIM’s operating budget
Single Non-Profit Contribution

10% of SGIM’s operating budget

Appendix 2. Template for proposals to SGIM for research or educational projects requiring SGIM’s participation and external funding.

PROPOSAL FOR AN EXTERNALLY-FUNDED SGIM RESEARCH OR EDUCATIONAL PROJECT

COVER PAGE (limit: one page)

Name of Principal Proponent (Must be an SGIM Member):

Contact Information for Principal Proponent (including fax number and email address):

Names and Institutions of Other Participating SGIM Members or Groups (Attach biographical sketches for the Key Project Personnel):

Title of Project:

Nature of Project: Research_____ Educational_____

SGIM’s Proposed Role: Applicant Organization______

Collaborator with Applicant Organization _____ (Provide name of applicant

organization):________________________________________________

Date Submitted:

Proposed External Funder (Indicate whether Proposed Funder is a For-Profit Company, and whether the Proposed Project is in Response to a Request for Proposals from the Funder. If possible, provide an internet URL of the Call for Proposals From the Funder):

Due Date for Application to the Funder (if applicable):

Principal Proponent Must Sign to Acknowledge the Following Statement:

“I have read and familiarized myself with the SGIM Policy on Acceptance and Disclosure of External Funds. I believe the project I am proposing that requires external funding is acceptable according to the policy.”

Signed:____________________________________

DESCRIPTION OF PROJECT (limit: 3 pages)

Project Objectives:

Methods:

Timetable:

Estimated Budget

Brief Description of the Proposed Funder:

Brief Description of how the Project is:

-consistent with the SGIM mission , “To promote improved patient care, teaching and research in primary care and general internal medicine”;

-judged to be particularly well suited to be carried out by SGIM as an organization; and

-judged to be unlikely to create undue competition with individual SGIM members’ pursuits of funding for their own research or educational projects.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.